Patents by Inventor Christoper B. Cooper

Christoper B. Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazole derivatives
    Patent number: 7078529
    Abstract: The invention provides compounds of formula 1 wherein R1, R2, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission.
    Type: Grant
    Filed: April 5, 2004
    Date of Patent: July 18, 2006
    Assignee: Pfizer Inc.
    Inventors: Mark A. Sanner, Chris J. Helal, Christoper B. Cooper, Frank S. Menniti, Patricia A. Seymour, Michael K. Ahlijanian, Anabella Villalobos, Lit-Fui Lau
  • Imidazole derivatives
    Publication number: 20040192750
    Abstract: The invention provides compounds of formula 1 1
    Type: Application
    Filed: April 5, 2004
    Publication date: September 30, 2004
    Applicant: Pfizer Inc
    Inventors: Mark A. Sanner, Chris J. Helal, Christoper B. Cooper, Frank S. Menniti, Patricia A. Seymour, Michael K. Ahlijanian, Anabella Villalobos, Lit-Fui Lau
  • Imidazole derivatives
    Patent number: 6756385
    Abstract: The invention provides compounds of formula 1 wherein R1, R2, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula 1 are indicated to have activity inhibiting cdk5, cdk2, and GSK-3. Pharmaceutical compositions and methods comprising compounds of formula 1 for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: June 29, 2004
    Assignee: Pfizer Inc.
    Inventors: Mark A. Sanner, Chris J. Helal, Christoper B. Cooper, Frank S. Menniti, Michael K. Ahlijanian, Annabella Villalobos, Lit-Fui Lau, Patricia A. Seymour
  • Imidazole derivatives
    Publication number: 20020119963
    Abstract: The invention provides compounds of formula 1 1
    Type: Application
    Filed: July 31, 2001
    Publication date: August 29, 2002
    Inventors: Mark A. Sanner, Chris J. Helal, Christoper B. Cooper, Frank S. Menniti, Michael K. Ahlijanian, Anabella Villalobos, Lit-Fui Lau, Patricia A. Seymour